Home › NDC Lookup › Labelers › A-S Medication Solutions

A-S Medication Solutions NDCs and Package Codes

This page lists NDC package records associated with labeler code 50090 (A-S Medication Solutions) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

5,112
Package NDCs
2,923
Products
2,922
Active listings
1
Discontinued
554
Ingredients
157
Therapeutic classes
62
Dosage forms
0
With NADAC pricing

Portfolio

By therapeutic class
ANTIHYPERLIPIDEMIC-HMGCOA REDUCTAS... 32
NSAIDS, CYCLOOXYGENASE INHIBITOR T... 26
SELECTIVE SEROTONIN REUPTAKE INHIB... 19
BETA-ADRENERGIC BLOCKING AGENTS 18
TOPICAL ANTI-INFLAMMATORY STEROIDA... 17
PROTON-PUMP INHIBITORS 16
ANTIHYPERTENSIVES, ANGIOTENSIN REC... 16
PENICILLIN ANTIBIOTICS 15
Top ingredients
levothyroxine sodium 74
Amoxicillin 48
metformin hydrochloride 45
Prednisone 43
Atorvastatin Calcium 42
Rosuvastatin Calcium 40
Ibuprofen 38
bupropion hydrochloride 32
Metoprolol Tartrate 27
Diclofenac Sodium 27
By dosage form
TABLET 997
TABLET, FILM COATED 665
CAPSULE 259
TABLET, EXTENDED RELEASE 104
CREAM 93
INJECTION, SOLUTION 80
SOLUTION 60
CAPSULE, DELAYED RELEASE 50

Browse records — 2,923 products

Drug / product Billing NDC NADAC / unit Status
INVOKANA canagliflozin 300 mg/1 TABLET, FILM COATED A-S · NDC 50090-4364-00 · 90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0) 50090-4364-00 — On market View →
INVOKANA canagliflozin 300 mg/1 TABLET, FILM COATED A-S · NDC 50090-5029-00 · 90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0) 50090-5029-00 — On market View →
INVOKANA canagliflozin 100 mg/1 TABLET, FILM COATED A-S · NDC 50090-5034-00 · 90 TABLET, FILM COATED in 1 BOTTLE (50090-5034-0) 50090-5034-00 — On market View →
INVOKANA canagliflozin 300 mg/1 TABLET, FILM COATED A-S · NDC 50090-5029-00 · 90 TABLET, FILM COATED in 1 BOTTLE (50090-5029-0) 50090-5029-00 — On market View →
IPOL POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U]/.5mL; 2 ANTIGEN (FORMALDEHYDE INACTIVATED) 8 [D'ag'U]/.5mL; 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 32 [D'ag'U]/.5mL INJECTION, SUSPENSION A-S · NDC 50090-1693-09 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0) 50090-1693-09 — On market View →
IPOL POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U]/.5mL; 2 ANTIGEN (FORMALDEHYDE INACTIVATED) 8 [D'ag'U]/.5mL; 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 32 [D'ag'U]/.5mL INJECTION, SUSPENSION A-S · NDC 50090-1693-09 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0) 50090-1693-09 — On market View →
Ipratropium Bromide .5 mg/2.5mL SOLUTION A-S · NDC 50090-6373-00 · J7644 · 25 POUCH in 1 CARTON (50090-6373-0) / 2.5 mL in 1 POUCH 50090-6373-00 — On market View →
Ipratropium Bromide .5 mg/2.5mL SOLUTION A-S · NDC 50090-0668-00 · J7644 · 1 POUCH in 1 CARTON (50090-0668-0) / 25 mL in 1 POUCH 50090-0668-00 — On market View →
Ipratropium Bromide 42 ug/1 SPRAY, METERED A-S · NDC 50090-5968-00 · 1 BOTTLE, PUMP in 1 CARTON (50090-5968-0) / 165 SPRAY, METERED in 1 BOTTLE, PUMP 50090-5968-00 — On market View →
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE 2.5 mg/3mL; .5 mg/3mL SOLUTION A-S · NDC 50090-1382-00 · J7620 · 30 VIAL in 1 CARTON (50090-1382-0) / 3 mL in 1 VIAL 50090-1382-00 — On market View →
Ipratropium Bromide and Albuterol Sulfate .5 mg/3mL; 3 mg/3mL SOLUTION A-S · NDC 50090-1669-00 · J7620 · 30 VIAL, SINGLE-DOSE in 1 POUCH (50090-1669-0) / 3 mL in 1 VIAL, SINGLE-DOSE 50090-1669-00 — On market View →
Irbesartan 150 mg/1 TABLET A-S · NDC 50090-1284-00 · 30 TABLET in 1 BOTTLE (50090-1284-0) 50090-1284-00 — On market View →
Irbesartan 300 mg/1 TABLET A-S · NDC 50090-2017-00 · 30 TABLET in 1 BOTTLE (50090-2017-0) 50090-2017-00 — On market View →
Irbesartan 300 mg/1 TABLET A-S · NDC 50090-6938-00 · 90 TABLET in 1 BOTTLE (50090-6938-0) 50090-6938-00 — On market View →
Irbesartan 300 mg/1 TABLET A-S · NDC 50090-2978-00 · 30 TABLET in 1 BOTTLE (50090-2978-0) 50090-2978-00 — On market View →
Irbesartan 300 mg/1 TABLET A-S · NDC 50090-7622-00 · 90 TABLET in 1 BOTTLE (50090-7622-0) 50090-7622-00 — On market View →
ISENTRESS RALTEGRAVIR 400 mg/1 TABLET, FILM COATED A-S · NDC 50090-1085-00 · 60 TABLET, FILM COATED in 1 BOTTLE (50090-1085-0) 50090-1085-00 — On market View →
ISENTRESS RALTEGRAVIR 400 mg/1 TABLET, FILM COATED A-S · NDC 50090-1085-00 · 60 TABLET, FILM COATED in 1 BOTTLE (50090-1085-0) 50090-1085-00 — On market View →
Isoniazid 100 mg/1 TABLET A-S · NDC 50090-0410-00 · 100 TABLET in 1 BOTTLE (50090-0410-0) 50090-0410-00 — On market View →
Isoniazid 300 mg/1 TABLET A-S · NDC 50090-0370-00 · 50 TABLET in 1 BOTTLE (50090-0370-0) 50090-0370-00 — On market View →
isoniazid 300 mg/1 TABLET A-S · NDC 50090-7660-03 · 30 TABLET in 1 BOTTLE (50090-7660-3) 50090-7660-03 — On market View →
Isopropyl Alcohol .7 mL/1 SWAB A-S · NDC 50090-6279-00 · 100 PACKET in 1 BOX (50090-6279-0) / 1 SWAB in 1 PACKET 50090-6279-00 — On market View →
Isosorbide Mononitrate 30 mg/1 TABLET, EXTENDED RELEASE A-S · NDC 50090-5686-00 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5686-0) 50090-5686-00 — On market View →
ISOSORBIDE MONONITRATE 60 mg/1 TABLET, EXTENDED RELEASE A-S · NDC 50090-6661-00 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6661-0) 50090-6661-00 — On market View →
ISOSORBIDE MONONITRATE 30 mg/1 TABLET, EXTENDED RELEASE A-S · NDC 50090-6798-00 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6798-0) 50090-6798-00 — On market View →
ISOSORBIDE MONONITRATE 30 mg/1 TABLET, EXTENDED RELEASE A-S · NDC 50090-7496-00 · 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7496-0) 50090-7496-00 — On market View →
Isosorbide Mononitrate 30 mg/1 TABLET, EXTENDED RELEASE A-S · NDC 50090-7038-00 · 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7038-0) 50090-7038-00 — On market View →
Ivermectin 3 mg/1 TABLET A-S · NDC 50090-5587-00 · 2 BLISTER PACK in 1 CARTON (50090-5587-0) / 10 TABLET in 1 BLISTER PACK 50090-5587-00 — On market View →
JANUMET SITAGLIPTIN and METFORMIN HYDROCHLORIDE 50 mg/1; 1000 mg/1 TABLET, FILM COATED A-S · NDC 50090-5502-00 · 60 TABLET, FILM COATED in 1 BOTTLE (50090-5502-0) 50090-5502-00 — On market View →
JANUMET SITAGLIPTIN and METFORMIN HYDROCHLORIDE 50 mg/1; 500 mg/1 TABLET, FILM COATED A-S · NDC 50090-5616-00 · 60 TABLET, FILM COATED in 1 BOTTLE (50090-5616-0) 50090-5616-00 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.